Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 4 | Acta Veterinaria Scandinavica

Fig. 4

From: Improved pharmacotherapy after revised dosing regimens of two slow-release formulations of benzylpenicillin in an Actinobacillus pleuropneumoniae infection model in pigs

Fig. 4

Parallel Tukey boxplots of the total white blood cell count in pigs. The boxplots are made of data from the first 5 days after inoculation with Actinobacillus pleuropneumonia serotype 2. Benzylpenicillin treatment was initiated at the onset of clinical signs which occurred within 24 h after inoculation (Day 0). The treatment group nomenclature is: the medicinal product, either procaine benzylpenicillin in a water suspension (ETH) or procaine benzylpenicillin in an oil suspension (UPA); dose in mg/kg; dose frequency (once or twice daily) and treatment duration in days. For example, ETH20-2 × 3 should read as: procaine benzylpenicillin in a water suspension 20 mg/kg bodyweight twice daily for three days

Back to article page

Acta Veterinaria Scandinavica

ISSN: 1751-0147